- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenomics of glinides
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 16, Issue 1, Pages 45-60
Publisher
Future Medicine Ltd
Online
2015-01-06
DOI
10.2217/pgs.14.152
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Zinc–rs13266634 and the Arrival of Diabetes Pharmacogenetics: The “Zinc Mystique”
- (2014) Nisa M. Maruthur et al. DIABETES
- Comparison of repaglinide and metformin monotherapy as an initial therapy in Chinese patients with newly diagnosed type 2 diabetes mellitus
- (2014) Fu-Sheng Fang et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Zinc transport and diabetes risk
- (2014) Ewan Pearson NATURE GENETICS
- Quantitative Assessment of the Effect of KCNJ11 Gene Polymorphism on the Risk of Type 2 Diabetes
- (2014) Ling Qiu et al. PLoS One
- UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation
- (2014) A. Vozza et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- State of the art paper The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus
- (2013) Rodolfo Guardado-Mendoza et al. Archives of Medical Science
- Mitiglinide for type 2 diabetes treatment
- (2013) Haley M Phillippe et al. EXPERT OPINION ON PHARMACOTHERAPY
- The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance
- (2013) Motoyuki Tamaki et al. JOURNAL OF CLINICAL INVESTIGATION
- NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes
- (2012) Zhi-Cheng Gong et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide
- (2012) Lisa Kitasato et al. Cardiovascular Diabetology
- KCNQ1 gene polymorphisms are associated with the therapeutic efficacy of repaglinide in Chinese Type 2 diabetic patients
- (2012) Xing-Ping Dai et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Repaglinide
- (2012) Lesley J. Scott DRUGS
- Effect of CYP2C9 and SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of nateglinide in healthy Chinese male volunteers
- (2012) Yu Cheng et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- IGF2BP2 and IGF2 genetic effects in diabetes and diabetic nephropathy
- (2012) Tianwei Gu et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- The Influence of MDR1 G2677T/A Genetic Polymorphisms on the Pharmacokinetics of Repaglinide in Healthy Chinese Volunteers
- (2012) Qian Xiang et al. PHARMACOLOGY
- NAMPT -3186C/T polymorphism affects repaglinide response in Chinese patients with Type 2 diabetes mellitus
- (2011) Fei-Feng Sheng et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Effects of KCNQ1 Polymorphisms on the Therapeutic Efficacy of Oral Antidiabetic Drugs in Chinese Patients With Type 2 Diabetes
- (2011) W Yu et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Postprandial Blood Glucose Predicts Cardiovascular Events and All-Cause Mortality in Type 2 Diabetes in a 14-Year Follow-Up: Lessons from the San Luigi Gonzaga Diabetes Study
- (2011) F. Cavalot et al. DIABETES CARE
- Efficacy and safety of mitiglinide versus nateglinide in newly diagnose patients with type 2 diabetes mellitus: a randomized double blind trial
- (2011) L. Li et al. DIABETES OBESITY & METABOLISM
- UCP2 −866G/A and Ala55Val, and UCP3 −55C/T polymorphisms in association with type 2 diabetes susceptibility: a meta-analysis study
- (2011) K. Xu et al. DIABETOLOGIA
- Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteers
- (2011) Jiake He et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A
- (2011) Veronica Y. Lang et al. Pharmacogenetics and Genomics
- IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population
- (2010) Qiong Huang et al. ACTA PHARMACOLOGICA SINICA
- A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese
- (2010) Wen Qin et al. ACTA PHARMACOLOGICA SINICA
- Mitiglinide: A Novel Agent for the Treatment of Type 2 Diabetes Mellitus
- (2010) Haley M Phillippe et al. ANNALS OF PHARMACOTHERAPY
- KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) Polymorphisms Affect Therapeutic Efficacy of Repaglinide in Chinese Patients With Type 2 Diabetes
- (2010) M Yu et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Additive hypoglycaemic effect of nateglinide and exogenous glucagon-like peptide-1 in type 2 diabetes
- (2010) P.M. Bell et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Efficacy and safety of mitiglinide in diabetic patients on maintenance hemodialysis
- (2010) Masanori Abe et al. ENDOCRINE JOURNAL
- Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients
- (2010) Qiong Huang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- CYP3A4 Genetic Polymorphism Influences Repaglinide’s Pharmacokinetics
- (2010) A.B. Ruzilawati et al. PHARMACOLOGY
- A Variant in the KCNQ1 Gene Predicts Future Type 2 Diabetes and Mediates Impaired Insulin Secretion
- (2009) A. Jonsson et al. DIABETES
- Association of genetic variants of NOS1AP with type 2 diabetes in a Chinese population
- (2009) C. Hu et al. DIABETOLOGIA
- NOS1AP variant associated with incidence of type 2 diabetes in calcium channel blocker users in the Atherosclerosis Risk in Communities (ARIC) study
- (2009) A. Y. Chu et al. DIABETOLOGIA
- Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese population
- (2009) C. Hu et al. DIABETOLOGIA
- Persistent Oxidative Stress Due to Absence of Uncoupling Protein 2 Associated with Impaired Pancreatic β-Cell Function
- (2009) Jingbo Pi et al. ENDOCRINOLOGY
- Combination therapy with mitiglinide and voglibose improves glycemic control in type 2 diabetic patients on hemodialysis
- (2009) Masanori Abe et al. EXPERT OPINION ON PHARMACOTHERAPY
- IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes
- (2009) Jan Christiansen et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Association ofKCNJ11andABCC8genetic polymorphisms with response to repaglinide in Chinese diabetic patients1
- (2008) Ya-yi HE et al. ACTA PHARMACOLOGICA SINICA
- The effect ofSLCO1B1polymorphism on repaglinide pharmacokinetics persists over a wide dose range
- (2008) Annikka Kalliokoski et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Common Variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE Genes Are Associated With Type 2 Diabetes and Impaired Fasting Glucose in a Chinese Han Population
- (2008) Y. Wu et al. DIABETES
- Implication of Genetic Variants Near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in Type 2 Diabetes and Obesity in 6,719 Asians
- (2008) M. C.Y. Ng et al. DIABETES
- Interaction of Oral Antidiabetic Drugs With Hepatic Uptake Transporters: Focus on Organic Anion Transporting Polypeptides and Organic Cation Transporter 1
- (2008) I. Bachmakov et al. DIABETES
- Different Effects ofSLCO1B1Polymorphism on the Pharmacokinetics and Pharmacodynamics of Repaglinide and Nateglinide
- (2008) Annikka Kalliokoski et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus
- (2008) Kazuki Yasuda et al. NATURE GENETICS
- SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations
- (2008) Hiroyuki Unoki et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started